Fabian Raschke

Chief Financial Officer, Member of the Executive Board at Grünenthal Group - Worthington, IA, US

Fabian Raschke's Colleagues at Grünenthal Group
Johannes Noel

Director HR, Head HR German Sales Division

Contact Johannes Noel

Sven Zeising

Head Global HR - Commercial Operations

Contact Sven Zeising

Robert Sunjic

Vice President - Head of Business Unit Pain

Contact Robert Sunjic

Vitor Lavinas

Integrated Business Planning Manager

Contact Vitor Lavinas

Guillaume Jovenet

Global Manufacturing Senior Vice President

Contact Guillaume Jovenet

View All Fabian Raschke's Colleagues
Fabian Raschke's Contact Details
HQ
49-241-569-0
Location
Company
Grünenthal Group
Fabian Raschke's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about Fabian Raschke
Fabian Raschke currently works for Grünenthal Group.
Fabian Raschke's role at Grünenthal Group is Chief Financial Officer, Member of the Executive Board.
Fabian Raschke's email address is ***@grunenthal.com. To view Fabian Raschke's full email address, please signup to ConnectPlex.
Fabian Raschke works in the Pharmaceuticals industry.
Fabian Raschke's colleagues at Grünenthal Group are Johannes Noel, Daniel Hartweg, Sven Zeising, Robert Sunjic, Vitor Lavinas, Marc Schiller, Guillaume Jovenet and others.
Fabian Raschke's phone number is 49-241-569-0
See more information about Fabian Raschke